“…To assess if such AIS plasticity actually occur in schizophrenia, we used postnatal MK-801 (an NMDA receptor antagonist) model. Transient exposure to MK-801 during the neonatal period causes behavioral changes in rodents such as hyperlocomotion, stereotyped behavior, sensorimotor gating, and cognitive deficits representing schizophrenia-like symptoms (Feinstein & Kritzer, 2013;Furuie, Yamada, & Ichitani, 2013;Nozari, Shabani, Hadadi, & Atapour, 2014, Nozari, Mansouri, Shabani, Nozari, & Atapour, 2015Nozari, Shabani, Farhangi, Mazhari, & Atapour, 2015;Zhou, Chen, Hu, Mao, & Kong, 2013). Underlying these behavioral changes are a decrease in the function of different neurotransmitter systems such as glutamatergic, dopaminergic, and GABAergic system (Abekawa, Ito, Nakagawa, & Koyama, 2007;Hoftman & Lewis, 2011;Jones, Corbin, & Huntsman, 2014;Weinstein et al, 2016).…”